TGFB2 and prostate carcinoma: Several studies have reported the increase of TGF-β isoforms in prostate cancer [142, 145–147, 197, 198], however our study shows a significant decrease in TGF-β2 and TGF-β3 gene expression and no differential expression of TGF-β1.